Repeatable battery for the assessment of neuropsychological status and its relationship to biomarkers of Alzheimer’s disease

References

• ADNI2. (2020). Alzheimer’s disease neuroimaging initiative: ADNI2 procedures manual. https://adni.loni.usc.edu/wp-content/uploads/2008/07/adni2-procedures-manual.pdf
   Google Scholar
• Ahern, E., & Semkovska, M. (2017). Cognitive functioning in the first-episode of major depressive disorder: A systematic review and meta-analysis. Neuropsychology, 31(1), 52–72. https://doi.org/10.1037/neu0000319
   PubMed Web of Science ®Google Scholar
• Benjamin, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B (Methodological), 57(1), 289–300. https://doi.org/10.1111/j.2517-6161.1995.tb02031.x
   Web of Science ®Google Scholar
• Bondi, M. W., Edmonds, E. C., Jak, A. J., Clark, L. R., Delano-Wood, L., McDonald, C. R., Nation, D. A., Libon, D. J., Au, R., Galasko, D., & Salmon, D. P. (2014). Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. Journal of Alzheimer’s Disease: JAD, 42(1), 275–289. https://doi.org/10.3233/JAD-140276
   PubMed Web of Science ®Google Scholar
• Burton, R. L., Enright, J., O’Connell, M. E., Lanting, S., & Morgan, D. (2015). RBANS embedded measures of suboptimal effort in dementia: Effort scale has a lower failure rate than the effort index. Archives of Clinical Neuropsychology, 30(1), 1–6. https://doi.org/10.1093/arclin/acu070
   PubMed Web of Science ®Google Scholar
• Caldwell, J. Z. K., Berg, J. L., Shan, G., Cummings, J. L., Banks, S. J., & Alzheimer’s Disease Neuroimaging Initiative. (2018). Sex moderates the impact of diagnosis and amyloid PET positivity on hippocampal subfield volume. Journal of Alzheimer’s Disease: JAD, 64(1), 79–89. https://doi.org/10.3233/JAD-180028
   PubMed Web of Science ®Google Scholar
• Clark, J. H., Hobson, V. L., & O’Bryant, S. E. (2010). Diagnostic accuracy of percent retention scores on RBANS verbal memory subtests for the diagnosis of Alzheimer’s disease and mild cognitive impairment. Archives of Clinical Neuropsychology, 25(4), 318–326. https://doi.org/10.1093/arclin/acq023
   PubMed Web of Science ®Google Scholar
• Cooley, S. A., Heaps, J. M., Bolzenius, J. D., Salminen, L. E., Baker, L. M., Scott, S. E., & Paul, R. H. (2015). Longitudinal change in performance on the montreal cognitive assessment in older adults. The Clinical Neuropsychologist, 29(6), 824–835. https://doi.org/10.1080/13854046.2015.1087596
   PubMed Web of Science ®Google Scholar
• De Tollis, M., De Simone, M. S., Perri, R., Fadda, L., Caltagirone, C., & Carlesimo, G. A. (2021). Verbal and spatial memory spans in mild cognitive impairment. Acta Neurologica Scandinavica, 144(4), 383–393. https://doi.org/10.1111/ane.13470
   PubMed Web of Science ®Google Scholar
• Duff, K., Foster, N. L., Dennett, K., Hammers, D. B., Zollinger, L. V., Christian, P. E., Butterfield, R. I., Beardmore, B. E., Wang, A. Y., Morton, K. A., & Hoffman, J. M. (2013). Amyloid deposition and cognition in older adults: the effects of premorbid intellect. Archives of Clinical Neuropsychology, 28(7), 665–671. https://doi.org/10.1093/arclin/act047
   PubMed Web of Science ®Google Scholar
• Duff, K., Hobson, V. L., Beglinger, L. J., & O’Bryant, S. E. (2010). Diagnostic accuracy of the RBANS in mild cognitive impairment: Limitations on assessing milder impairments. Archives of Clinical Neuropsychology, 25(5), 429–441. https://doi.org/10.1093/arclin/acq045
   PubMed Web of Science ®Google Scholar
• Duff, K., Humphreysclark, J., Obryant, S., Mold, J., Schiffer, R., & Sutker, P. (2008). Utility of the RBANS in detecting cognitive impairment associated with Alzheimer’s disease: Sensitivity, specificity, and positive and negative predictive powers. Archives of Clinical Neuropsychology, 23(5), 603–612. https://doi.org/10.1016/j.acn.2008.06.004
   PubMed Web of Science ®Google Scholar
• Duff, K., Porter, S., Dixon, A., Suhrie, K., & Hammers, D. (2020). The independent living scale in amnestic mild cognitive impairment: Relationships to demographic variables and cognitive performance. Journal of Clinical and Experimental Neuropsychology, 42(7), 725–734. https://doi.org/10.1080/13803395.2020.1798884
   PubMed Web of Science ®Google Scholar
• Duff, K., & Ramezani, A. (2015). Regression-based normative formulae for the repeatable battery for the assessment of neuropsychological status for older adults. Archives of Clinical Neuropsychology, 30(7), 600–604. https://doi.org/10.1093/arclin/acv052
   PubMed Web of Science ®Google Scholar
• Duff, K., Schoenberg, M. R., Patton, D. E., Mold, J., Scott, J. G., & Adams, R. A. (2004). Predicting change with the RBANS in a community dwelling elderly sample. Journal of the International Neuropsychological Society: JINS, 10(6), 828–834. https://doi.org/10.1017/s1355617704106048
   PubMed Web of Science ®Google Scholar
• Duff, K., Schoenberg, M. R., Patton, D., Paulsen, J. S., Bayless, J. D., Mold, J., Scott, J. G., & Adams, R. L. (2005). Regression-based formulas for predicting change in RBANS subtests with older adults. Archives of Clinical Neuropsychology, 20(3), 281–290. https://doi.org/10.1016/j.acn.2004.07.007
   PubMed Web of Science ®Google Scholar
• Edmonds, E. C., Delano-Wood, L., Clark, L. R., Jak, A. J., Nation, D. A., McDonald, C. R., Libon, D. J., Au, R., Galasko, D., Salmon, D. P., & Bondi, M. W. (2015). Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 11(4), 415–424. https://doi.org/10.1016/j.jalz.2014.03.005
   PubMed Web of Science ®Google Scholar
• England, H. B., Gillis, M. M., & Hampstead, B. M. (2014). RBANS memory indices are related to medial temporal lobe volumetrics in healthy older adults and those with mild cognitive impairment. Archives of Clinical Neuropsychology, 29(4), 322–328. https://doi.org/10.1093/arclin/acu012
   PubMed Web of Science ®Google Scholar
• Enright, J., O’Connell, M. E., MacKinnon, S., & Morgan, D. G. (2015). Predictors of completion of executive-functioning tasks in a memory clinic dementia sample. Applied Neuropsychology. Adult, 22(6), 459–464. https://doi.org/10.1080/23279095.2014.992070
   PubMed Web of Science ®Google Scholar
• Fischl, B., & Dale, A. M. (2000). Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proceedings of the National Academy of Sciences of the United States of America, 97(20), 11050–11055. https://doi.org/10.1073/pnas.200033797
   PubMed Web of Science ®Google Scholar
• Fischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., Montillo, A., Makris, N., Rosen, B., & Dale, A. M. (2002). Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain. Neuron, 33(3), 341–355. https://doi.org/10.1016/S0896-6273(02)00569-X
   PubMed Web of Science ®Google Scholar
• Fischl, B., van der Kouwe, A., Destrieux, C., Halgren, E., Ségonne, F., Salat, D. H., Busa, E., Seidman, L. J., Goldstein, J., Kennedy, D., Caviness, V., Makris, N., Rosen, B., & Dale, A. M. (2004). Automatically parcellating the human cerebral cortex. Cerebral Cortex (New York, N.Y.: 1991), 14(1), 11–22. https://doi.org/10.1093/cercor/bhg087
   PubMed Web of Science ®Google Scholar
• Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189–198. https://doi.org/10.1016/0022-3956(75)90026-6
   PubMed Web of Science ®Google Scholar
• Freilich, B. M., & Hyer, L. A. (2007). Relation of the repeatable battery for assessment of neuropsychological status to measures of daily functioning in dementia. Psychological Reports, 101(1), 119–129. https://doi.org/10.2466/pr0.101.1.119-129
   PubMed Web of Science ®Google Scholar
• Ge, T., Sabuncu, M. R., Smoller, J. W., Sperling, R. A., Mormino, E. C., & Alzheimer’s Disease Neuroimaging Initiative. (2018). Dissociable influences of APOE ε4 and polygenic risk of AD dementia on amyloid and cognition. Neurology, 90(18), e1605–e1612. https://doi.org/10.1212/WNL.0000000000005415
   PubMed Web of Science ®Google Scholar
• Giffard, B., Desgranges, B., Nore-Mary, F., Lalevée, C., de la Sayette, V., Pasquier, F., & Eustache, F. (2001). The nature of semantic memory deficits in Alzheimer’s disease: New insights from hyperpriming effects. Brain: A Journal of Neurology, 124(Pt 8), 1522–1532. https://doi.org/10.1093/brain/124.8.1522
   PubMedGoogle Scholar
• Hammers, D. B., Atkinson, T. J., Dalley, B. C. A., Suhrie, K. R., Beardmore, B. E., Burrell, L. D., Horn, K. P., Rasmussen, K. M., Foster, N. L., Duff, K., & Hoffman, J. M. (2017). Relationship between (18)F-Flutemetamol uptake and RBANS performance in non-demented community-dwelling older adults. The Clinical Neuropsychologist, 31(3), 531–543. https://doi.org/10.1080/13854046.2016.1278039
   PubMed Web of Science ®Google Scholar
• Hammers, D. B., Atkinson, T. J., Dalley, B. C. A., Suhrie, K. R., Horn, K. P., Rasmussen, K. M., Beardmore, B. E., Burrell, L. D., Duff, K., & Hoffman, J. M. (2017). Amyloid positivity using [18F]Flutemetamol-PET and cognitive deficits in nondemented community-dwelling older adults. American Journal of Alzheimer’s Disease & Other Dementiasr, 32(6), 320–328. https://doi.org/10.1177/1533317517698795
   PubMed Web of Science ®Google Scholar
• Hammers, D. B., Suhrie, K. R., Porter, S. M., Dixon, A. M., & Duff, K. (2020a). Generalizability of reliable change equations for the RBANS over one year in community-dwelling older adults. Journal of Clinical and Experimental Neuropsychology, 42(4), 394–405. https://doi.org/10.1080/13803395.2020.1740654
   PubMed Web of Science ®Google Scholar
• Hammers, D. B., Suhrie, K. R., Porter, S. M., Dixon, A. M., & Duff, K. (2020b). Validation of one-year reliable change in the RBANS for community-dwelling older adults with amnestic mild cognitive impairment. The Clinical Neuropsychologist, 1–24. https://doi.org/10.1080/13854046.2020.1807058
   Google Scholar
• Heyanka, D. J., Scott, J. G., & Adams, R. L. (2015). Improving the diagnostic accuracy of the RBANS in mild cognitive impairment with construct-consistent measures. Applied Neuropsychology. Adult, 22(1), 32–41. https://doi.org/10.1080/23279095.2013.827574
   PubMed Web of Science ®Google Scholar
• Hobson, V. L., Hall, J. R., Humphreys-Clark, J. D., Schrimsher, G. W., & O’Bryant, S. E. (2010). Identifying functional impairment with scores from the repeatable battery for the assessment of neuropsychological status (RBANS). International Journal of Geriatric Psychiatry, 25(5), 525–530. https://doi.org/10.1002/gps.2382
   PubMed Web of Science ®Google Scholar
• Holtzman, D. M., Herz, J., & Bu, G. (2012). Apolipoprotein E and apolipoprotein E receptors: Normal biology and roles in Alzheimer disease. Cold Spring Harbor Perspectives in Medicine, 2(3), a006312. https://doi.org/10.1101/cshperspect.a006312
   PubMed Web of Science ®Google Scholar
• Jiang, L., Cheng, Y., Li, Q., Tang, Y., Shen, Y., Li, T., Feng, W., Cao, X., Wu, W., Wang, J., & Li, C. (2014). Cross-sectional study of the association of cognitive function and hippocampal volume among healthy elderly adults. Shanghai Arch Psychiatry, 26(5), 280–287. https://doi.org/10.11919/j.issn.1002-0829.214036
   PubMedGoogle Scholar
• Karantzoulis, S., Novitski, J., Gold, M., & Randolph, C. (2013). The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Utility in detection and characterization of mild cognitive impairment due to Alzheimer’s disease. Archives of Clinical Neuropsychology, 28(8), 837–844. https://doi.org/10.1093/arclin/act057
   PubMed Web of Science ®Google Scholar
• Lim, Y. Y., & Mormino, E. C. (2017). APOE genotype and early β-amyloid accumulation in older adults without dementia. Neurology, 89(10), 1028–1034. https://doi.org/10.1212/WNL.0000000000004336
   PubMed Web of Science ®Google Scholar
• Lundqvist, R., Lilja, J., Thomas, B. A., Lotjonen, J., Villemagne, V. L., Rowe, C. C., & Thurfjell, L. (2013). Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, 54(8), 1472–1478. https://doi.org/10.2967/jnumed.112.115006
   PubMed Web of Science ®Google Scholar
• Mayeux, R., Stern, Y., Ottman, R., Tatemichi, T. K., Tang, M.-X., Maestre, G., Ngai, C., Tycko, B., & Ginsberg, H. (1993). The apolipoprotein epsilon 4 allele in patients with Alzheimer’s disease. Annals of Neurology, 34(5), 752–754. https://doi.org/10.1002/ana.410340527
   PubMed Web of Science ®Google Scholar
• McDermott, A. T., & DeFilippis, N. A. (2010). Are the indices of the RBANS sufficient for differentiating Alzheimer’s disease and subcortical vascular dementia? Archives of Clinical Neuropsychology, 25(4), 327–334. https://doi.org/10.1093/arclin/acq028
   PubMed Web of Science ®Google Scholar
• Melrose, R. J., Harwood, D., Khoo, T., Mandelkern, M., & Sultzer, D. L. (2013). Association between cerebral metabolism and Rey-Osterrieth Complex Figure Test performance in Alzheimer’s disease. Journal of Clinical and Experimental Neuropsychology, 35(3), 246–258. https://doi.org/10.1080/13803395.2012.763113
   PubMed Web of Science ®Google Scholar
• Morgan, D. R., Linck, J., Scott, J., Adams, R., & Mold, J. (2010). Assessment of the RBANS Visual and Verbal Indices in a sample of neurologically impaired elderly participants. The Clinical Neuropsychologist, 24(8), 1365–1378. https://doi.org/10.1080/13854046.2010.516769
   PubMed Web of Science ®Google Scholar
• Mormino, E. C., Betensky, R. A., Hedden, T., Schultz, A. P., Amariglio, R. E., Rentz, D. M., Johnson, K. A., & Sperling, R. A. (2014). Synergistic effect of beta-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. JAMA Neurology, 71(11), 1379–1385. https://doi.org/10.1001/jamaneurol.2014.2031
   PubMed Web of Science ®Google Scholar
• Morris, J. C. (1993). The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology, 43(11), 2412–2414. https://doi.org/10.1212/wnl.43.11.2412-a
   PubMed Web of Science ®Google Scholar
• O’Bryant, S. E., Falkowski, J., Hobson, V., Johnson, L., Hall, J., Schrimsher, G. W., Win, O., Ngo, B., & Dentino, A. (2011). Executive functioning mediates the link between other neuropsychological domains and daily functioning: A project FRONTIER study. International Psychogeriatrics, 23(1), 107–113. https://doi.org/10.1017/S1041610210000967
   PubMed Web of Science ®Google Scholar
• O’Connell, M. E., Gould, B., Ursenbach, J., Enright, J., & Morgan, D. G. (2019). Reliable change and minimum clinically important difference (MCID) of the Repeatable Battery for the Assessment of Neuropsychology Status (RBANS) in a heterogeneous dementia sample: Support for reliable change methods but not the MCID. Applied Neuropsychology. Adult, 26(3), 268–274. https://doi.org/10.1080/23279095.2017.1413575
   PubMed Web of Science ®Google Scholar
• O’Mahar, K. M., Duff, K., Scott, J. G., Linck, J. F., Adams, R. L., & Mold, J. W. (2012). Brief report: The temporal stability of the Repeatable Battery for the Assessment of Neuropsychological Status Effort Index in geriatric samples. Archives of Clinical Neuropsychology, 27(1), 114–118. https://doi.org/10.1093/arclin/acr072
   PubMed Web of Science ®Google Scholar
• Olson, L. T., Smerbeck, A., Figueroa, C. M., Raines, J. M., Szigeti, K., Schretlen, D. J., & Benedict, R. H. B. (2021). Preliminary validation of the global neuropsychological assessment in Alzheimer’s disease and healthy volunteers. Assessment. https://doi.org/10.1177/1073191121991221
   Google Scholar
• Ottoy, J., Niemantsverdriet, E., Verhaeghe, J., De Roeck, E., Struyfs, H., Somers, C., Wyffels, L., Ceyssens, S., Van Mossevelde, S., Van den Bossche, T., Van Broeckhoven, C., Ribbens, A., Bjerke, M., Stroobants, S., Engelborghs, S., & Staelens, S. (2019). Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and (18)F-FDG-PET imaging. Neuroimage: Clinical, 22, 101771. https://doi.org/10.1016/j.nicl.2019.101771
   PubMed Web of Science ®Google Scholar
• Park, S. Y., Byun, B. H., Kim, B. I., Lim, S. M., Ko, I. O., Lee, K. C., Kim, K. M., Kim, Y. K., Lee, J.-Y., Bu, S. H., Kim, J. H., Chi, D. Y., & Ha, J. H. (2020). The correlation of neuropsychological evaluation with 11C-PiB and 18F-FC119S amyloid PET in mild cognitive impairment and Alzheimer disease. Medicine, 99(16), e19620. https://doi.org/10.1097/MD.0000000000019620
   PubMed Web of Science ®Google Scholar
• Paul, R., Lane, E. M., Tate, D. F., Heaps, J., Romo, D. M., Akbudak, E., Niehoff, J., & Conturo, T. E. (2011). Neuroimaging signatures and cognitive correlates of the Montreal cognitive assessment screen in a nonclinical elderly sample. Archives of Clinical Neuropsychology, 26(5), 454–460. https://doi.org/10.1093/arclin/acr017
   PubMed Web of Science ®Google Scholar
• Peters, A. T., Jacobs, R. H., Crane, N. A., Ryan, K. A., Weisenbach, S. L., Ajilore, O., Lamar, M., Kassel, M. T., Gabriel, L. B., West, A. E., Zubieta, J.-K., & Langenecker, S. A. (2017). Domain-specific impairment in cognitive control among remitted youth with a history of major depression. Early Intervention in Psychiatry, 11(5), 383–392. https://doi.org/10.1111/eip.12253
   PubMed Web of Science ®Google Scholar
• Petersen, R. C., Smith, G. E., Ivnik, R. J., Tangalos, E. G., Schaid, D. J., Thibodeau, S. N., Kokmen, E., Waring, S. C., & Kurland, L. T. (1995). Apolipoprotein E status as a predictor of the development of Alzheimer’s disease in memory-impaired individuals. JAMA, 273(16), 1274–1278. https://doi.org/10.1001/jama.1995.03520400044042
   PubMed Web of Science ®Google Scholar
• Phillips, R., Qi, G., Collinson, S. L., Ling, A., Feng, L., Cheung, Y. B., & Ng, T. P. (2015). The minimum clinically important difference in the repeatable battery for the assessment of neuropsychological status. The Clinical Neuropsychologist, 29(7), 905–923. https://doi.org/10.1080/13854046.2015.1107137
   PubMed Web of Science ®Google Scholar
• Randolph, C. (2012). Repeatable battery for the assessment of neuropsychological status. The Psychological Corporation.
   Google Scholar
• Randolph, C. (2019). The utility of episodic memory cut-off scores for inclusion in clinical trials for early symptomatic Alzheimer disease. The American Journal of Geriatric Psychiatry, 27(12), 1428–1432. https://doi.org/10.1016/j.jagp.2019.08.012
   PubMed Web of Science ®Google Scholar
• Rascovsky, K., Salmon, D. P., Hansen, L. A., Thal, L. J., & Galasko, D. (2007). Disparate letter and semantic category fluency deficits in autopsy-confirmed frontotemporal dementia and Alzheimer’s disease. Neuropsychology, 21(1), 20–30. https://doi.org/10.1037/0894-4105.21.1.20
   PubMed Web of Science ®Google Scholar
• Schmitt, A. L., Livingston, R. B., Smernoff, E. N., Reese, E. M., Hafer, D. G., & Harris, J. B. (2010). Factor analysis of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in a large sample of patients suspected of dementia. Applied Neuropsychology, 17(1), 8–17. https://doi.org/10.1080/09084280903297719
   PubMed Web of Science ®Google Scholar
• Silva, D., Guerreiro, M., Maroco, J., Santana, I., Rodrigues, A., Bravo Marques, J., & de Mendonca, A. (2012). Comparison of four verbal memory tests for the diagnosis and predictive value of mild cognitive impairment. Dementia and Geriatric Cognitive Disorders Extra, 2(1), 120–131. https://doi.org/10.1159/000336224
   PubMedGoogle Scholar
• Skinner, J., Carvalho, J. O., Potter, G. G., Thames, A., Zelinski, E., Crane, P. K., & Gibbons, L. E. (2012). The Alzheimer’s Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-Plus): An expansion of the ADAS-Cog to improve responsiveness in MCI. Brain Imaging and Behavior, 6(4), 489–501. https://doi.org/10.1007/s11682-012-9166-3
   PubMed Web of Science ®Google Scholar
• Sunderland, J. J., & Christian, P. E. (2015). Quantitative PET/CT scanner performance characterization based upon the society of nuclear medicine and molecular imaging clinical trials network oncology clinical simulator phantom. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, 56(1), 145–152. https://doi.org/10.2967/jnumed.114.148056
   PubMed Web of Science ®Google Scholar
• Teng, E., Ward, M., Manser, P. T., Sanabria-Bohorquez, S., Ray, R. D., Wildsmith, K. R., Baker, S., Kerchner, G. A., & Weimer, R. M. (2019). Cross-sectional associations between [18F]GTP1 tau PET and cognition in Alzheimer’s disease. Neurobiology of Aging, 81, 138–145. https://doi.org/10.1016/j.neurobiolaging.2019.05.026
   PubMed Web of Science ®Google Scholar
• Thaler, N. S., Hill, B. D., Duff, K., Mold, J., & Scott, J. G. (2015). Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) intraindividual variability in older adults: Associations with disease and mortality. Journal of Clinical and Experimental Neuropsychology, 37(6), 622–629. https://doi.org/10.1080/13803395.2015.1039962
   PubMed Web of Science ®Google Scholar
• Thurfjell, L., Lilja, J., Lundqvist, R., Buckley, C., Smith, A., Vandenberghe, R., & Sherwin, P. (2014). Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: Concordance with visual image reads. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, 55(10), 1623–1628. https://doi.org/10.2967/jnumed.114.142109
   PubMed Web of Science ®Google Scholar
• Tsatali, M., Poptsi, E., Moraitou, D., Agogiatou, C., Bakoglidou, E., Gialaouzidis, M., Papasozomenou, C., Soumpourou, A., & Tsolaki, M. (2021). Discriminant validity of the WAIS-R digit symbol substitution test in subjective cognitive decline, mild cognitive impairment (amnestic subtype) and Alzheimer’s disease dementia (ADD) in Greece. Brain Sciences, 11(7), 881. https://doi.org/10.3390/brainsci11070881
   PubMed Web of Science ®Google Scholar
• Vandenberghe, R., Van Laere, K., Ivanoiu, A., Salmon, E., Bastin, C., Triau, E., Hasselbalch, S., Law, I., Andersen, A., Korner, A., Minthon, L., Garraux, G., Nelissen, N., Bormans, G., Buckley, C., Owenius, R., Thurfjell, L., Farrar, G., & Brooks, D. J. (2010). 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. Annals of Neurology, 68(3), 319–329. https://doi.org/10.1002/ana.22068
   PubMed Web of Science ®Google Scholar
• Wechsler, D. (1987). Manual for the Weschler Memory Scale - Revised. The Psychological Corporation.
   Google Scholar
• Wilkinson, G. S., & Robertson, G. J. (2006). WRAT 4: Wide Range Achievement Test, professional manual. Psychological Assessment Resources, Inc.
   Google Scholar
• Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O. (1982). Development and validation of a geriatric depression screening scale: A preliminary report. Journal of Psychiatric Research, 17(1), 37–49. https://doi.org/10.1016/0022-3956(82)90033-4
   PubMed Web of Science ®Google Scholar
• Yester, M., Al-Senan, R., & White, S. (2014). NEMA testing of GE Discovery 710 PET scanner compared to a simplified protocol for routine testing of PET scanners. Journal of Nuclear Medicine, 55, 2157.
   Google Scholar